Compare BLLN & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | INSW |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | N/A | 2016 |
| Metric | BLLN | INSW |
|---|---|---|
| Price | $118.17 | $79.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $126.71 | $77.00 |
| AVG Volume (30 Days) | ★ 782.3K | 514.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.75 |
| Revenue | N/A | ★ $843,302,000.00 |
| Revenue This Year | $46.29 | $10.20 |
| Revenue Next Year | $30.14 | N/A |
| P/E Ratio | ★ N/A | $14.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $61.96 | $36.03 |
| 52 Week High | $138.70 | $92.66 |
| Indicator | BLLN | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 67.16 | 42.73 |
| Support Level | $79.07 | $75.22 |
| Resistance Level | $138.70 | $85.50 |
| Average True Range (ATR) | 6.87 | 3.90 |
| MACD | 1.10 | -0.05 |
| Stochastic Oscillator | 97.91 | 24.23 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. Its fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.